Copyright © 2013 Knight Sac Media. All rights reserved.http://www.siliconinvestor.com/subject.aspx?subjectid=56058[graphic]Subject 11419 Nektar Therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. Cancer and Pain Productshttp://www.siliconinvestor.com/images/Logo380x132.pnghttp://www.siliconinvestor.com/subject.aspx?subjectid=5605838013210ghmmI remember them talking about this at their R&D Day Event last year. Its certainly early but I thought it seems like an intriguing compound with a good deal of potential. I think efficacy is not the major barrier but rather tolerability will be the key. If this drug could reduce the need to have to hospitalize patie...http://www.siliconinvestor.com/readmsg.aspx?msgid=288215254/7/2013 10:45:40 PMArthur Radley Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013NKTR-214 Demonstrates Improved Efficacy in Resistant Preclinical Melanoma Model Through Preferential Activation of Tumor Killing Immune Cell Subtype SAN FRANCISCO,...http://www.siliconinvestor.com/readmsg.aspx?msgid=288208884/7/2013 2:06:10 PMArthur Radleyhttp://www.siliconinvestor.com/readmsg.aspx?msgid=287979293/25/2013 10:01:35 AMghmmThe replay is available now. I only heard parts of the presentation and didn't catch any mention of NKTR during the small parts I heard. media-server.com  If that link doesn't work can get it from here astrazeneca.com  There was a blurb on amikacin inhaled. I think data was presented somewhere either late last week...http://www.siliconinvestor.com/readmsg.aspx?msgid=287932453/22/2013 10:30:26 AMArthur RadleyNice move in the stock today--got within a few pennies of breaking out above a new 52 week high. I'm assuming the move was helped by the Astra Zeneca forum today where they updated their game plan for future growth. I think it safe to assume there was some 'spin' in their extensive presentation..but it was nice to see...http://www.siliconinvestor.com/readmsg.aspx?msgid=287922973/21/2013 8:01:55 PMArthur Radleyseekingalpha.com  Detailed article about the various programs that NKTR is involved. Writer indicates he works in the health field--could be hospital orderly, for all I know--but the article is lengthy and detailed.http://www.siliconinvestor.com/readmsg.aspx?msgid=287905323/21/2013 8:35:07 AMghmmLooks like we got that break above 9.50 :-). I didn't see any news and heard the Cowen call this morning. Nothing I thought new in it though continue to be generally bullish. I think since the setback with the other opioid drug and the Street articles people have discounted NKTR-118. If they file in Q3 and it gets ...http://www.siliconinvestor.com/readmsg.aspx?msgid=287606473/5/2013 10:11:49 AMArthur Radleyseekingalpha.com  This is a link for the transcript for the CC----I always like to hear the CCs for any voice nuances, but then I prefer reading the transcript for the details. Enjoy the weekend!http://www.siliconinvestor.com/readmsg.aspx?msgid=287549733/1/2013 6:08:15 PMghmmCongrats on CLDX. I thought I missed it in the 6-7 range so never looked more closely then and so I'm on the sidelines on this one. Hope does well for you! I also like that NKTR has a lot going for them. I am more of a partner person rather than a go-it-alone no matter how much HR plays up the pain I would prefer p...http://www.siliconinvestor.com/readmsg.aspx?msgid=287543933/1/2013 12:55:25 PMArthur RadleyGood Q report----pipeline is nice for such a small company. Next milestone is MAPP/Allergan drug approval in next few weeks. Hope you took a look at CLDX----------rocket launch today! Zooom! Zooom!http://www.siliconinvestor.com/readmsg.aspx?msgid=287542383/1/2013 11:58:57 AMArthur RadleyHas been a strange day of trading---moved up and then down, but as I write it is now above morning level and volume seems to be building. Chart is looking good for a breakout--but the $9.50 level seems to be the resistance level--so we need to break above $9.50 on improving volume. Q conference call coming up on Thurs...http://www.siliconinvestor.com/readmsg.aspx?msgid=287477872/26/2013 1:59:31 PMghmmhttp://www.siliconinvestor.com/readmsg.aspx?msgid=287468582/26/2013 3:20:50 AMArthur RadleyNKTR needs some good news after the (AFFY) debacle over the weekend. (AFFY) down nearly 90%--ouch! Tis good that NKTRs apparently didn't have much of their current price supported by the AFFY revenue stream--a stream that is now dry!http://www.siliconinvestor.com/readmsg.aspx?msgid=287448742/25/2013 8:58:00 AMghmmIt looks like the Amikacin trial is finally (really) going to get started. I was starting to give up on it :-) !http://clinicaltrials.gov/ct2/show/NCT00805168http://www.siliconinvestor.com/readmsg.aspx?msgid=287448582/25/2013 8:47:32 AMArthur RadleyLazard Capital Starts Nektar Therapeutics (NKTR) at Buy6:44 AM ET, 01/15/2013 - Street Insider Lazard Capital initiates coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy. PT $15.00. Shares of Nektar Therapeutics closed at $8.74 yesterday, with a 52 week range of $5.65-$10.98.http://www.siliconinvestor.com/readmsg.aspx?msgid=286647951/15/2013 9:37:45 AMArthur RadleyNKTR-118-We have a large, well-controlled 52-week open label safety study, the KODIAC-08 study, that was completed in December and that analysis is ongoing and we’ll give you an update as soon as that analysis is complete. We’ll provide you with a safety analysis update this quarter, but again, that was an open label s...http://www.siliconinvestor.com/readmsg.aspx?msgid=286566991/10/2013 8:00:27 PMArthur RadleyStill hope that Baxter has some news at ASH, but the other potential explanation for today's move is short covering. If Congress gets their act together on the budget, I still don't believe they will change the capital gains tax..........but there are probably some that want to lock in profits before 2013. One stock th...http://www.siliconinvestor.com/readmsg.aspx?msgid=2859133912/7/2012 4:39:03 PMghmmI was curious about the move and didn't see anything either. I thought the stock was cheap and bought back more in the 6's recently.http://www.siliconinvestor.com/readmsg.aspx?msgid=2859082712/7/2012 12:58:41 PMArthur RadleyASH conference starts this weekend in Atlanta--maybe Baxter will release info on their partnership drug with NKTR. They have in previous years(2010) given updates at this conference.......so maybe this is the reason for the activity today.http://www.siliconinvestor.com/readmsg.aspx?msgid=2859045912/7/2012 10:56:54 AMArthur RadleySomeone has struck a match under (NKTR) this morning--volume already at 700,000 and stock up 7%. The recent fall was brutal, but maybe the recovery will be quicker and better!http://www.siliconinvestor.com/readmsg.aspx?msgid=2859038012/7/2012 10:25:59 AMghmmThanks for posting the link! AZ sure seems to be fully behind it. The number of trials they are running is multiples of what other companies with similar agents are running. I imagine if one trial hits and the other doesn't (assuming safety is good) they'll run another trial to seek approval.http://www.siliconinvestor.com/readmsg.aspx?msgid=2849602610/24/2012 11:33:58 AMArthur Radleyastrazeneca.com  Coming data from AZN could be key for future applications for NKTR technology.http://www.siliconinvestor.com/readmsg.aspx?msgid=2849599810/24/2012 11:25:38 AMArthur Radleyseekingalpha.com  Market reaction was very positive for CEO's presentation at UBS today----impressive list of potential drugs in Phase 3, or will be shortly.http://www.siliconinvestor.com/readmsg.aspx?msgid=284201929/19/2012 6:06:06 PMghmmIt sounds like MAPP may take a while yet. I didn't see anything on NKTR and figured a delayed move to the AFFY news and pushing out the debt. I don't know if an analyst or two came out with a new report/target. Or maybe its just Martin Shkreli covering :-)http://www.siliconinvestor.com/readmsg.aspx?msgid=282711467/16/2012 7:52:22 PMArthur RadleyThat was the first thing I thought as this convertible note had been the overhang for the stock, but then it was solved last Tuesday, with their announcement. Wall Street has been aware of this situation, so IMO it wouldn't have taken them until today in order to figure out this issue. We are tracking 3million share...http://www.siliconinvestor.com/readmsg.aspx?msgid=282705907/16/2012 3:44:54 PMghmmPerhaps the AFFY news/move last week along with getting rid of (extending) the remaining debt. Until the royalty sale and now the financing that was a big overhang on the stock.http://www.siliconinvestor.com/readmsg.aspx?msgid=282703557/16/2012 1:57:25 PMArthur RadleyNice move today above the $8.50 resistance level---with heavy volume. Can't find any reason for the move---but mysteries on the upside are always good.http://www.siliconinvestor.com/readmsg.aspx?msgid=282702227/16/2012 1:15:59 PMArthur Radleymigraine.com  Positive article about the MAPP/NKTR migraine drug--Levadex----decision date is later this month from the FDA.http://www.siliconinvestor.com/readmsg.aspx?msgid=280034983/10/2012 4:40:12 PMArthur Radleyhuffingtonpost.com  Interesting article on the issue of painkiller meds-----and how those suffering are caught up in getting treatment.http://www.siliconinvestor.com/readmsg.aspx?msgid=280029183/10/2012 11:35:14 AMArthur RadleyToday's news helps remove the convertible debt issue that has held back the stock--now they need some good news on the pipeline to get the stock back into double digits............today's news has certainly helped!!! Nektar (NKTR) to Sell Royalties for CIMZIA, MIRCERA to Royalty Pharma for $124M 9:06 am ET 02/29/...http://www.siliconinvestor.com/readmsg.aspx?msgid=279795522/29/2012 9:40:53 AMArthur RadleyIn the last few day the 13-G filings have been huge for (NKTR). The following firms have filed announcing their position in the stock: Healthcor Blackrock PrimeCap Management Biotechnology Value Oppenheimerhttp://www.siliconinvestor.com/readmsg.aspx?msgid=279463942/13/2012 4:09:49 PMArthur Radleybizjournals.com  Nice feature story in SF Bizjournal----compelling story with broad pipeline.http://www.siliconinvestor.com/readmsg.aspx?msgid=278932831/20/2012 12:17:41 PMArthur RadleyMajor FDA decisions coming up in March---- 3/26 is date for FDA action on the (MAPP) NDA 3/27 is date for FDA action on the (AFFY) NDA Completed filling my position on (AFFY) today when it broke below the $7.00 point. Would be nice to see both drugs approved--fingers are crossed.http://www.siliconinvestor.com/readmsg.aspx?msgid=278700871/9/2012 2:38:32 PM